| 抗高血压药物研究现状及新进展 |
| |
| 引用本文： | 刘海洲,肖强,王志萍,张媛媛.抗高血压药物研究现状及新进展[J].化工科技市场,2008,31(6). |
| |
| 作者姓名： | 刘海洲 肖强 王志萍 张媛媛 |
| |
| 作者单位： | 青岛科技大学化工学院,山东青岛,266042 |
| |
| 摘 要： | 心血管疾病是威胁人类健康的头号杀手,而高血压是其中最为多见的疾病之一.近年来,高血压已经成为危害人类健康的主要杀手,引起了抗高血压药物市场的快速发展.有关资料显示,到2009年,全球降压药市场将超过580亿美元,预计年增长率将保持在7%左右.
|
| 关 键 词： | 高血压 心血管 血管紧张素 受体 |
Present situation and research progress of dyazide |
| |
| Liu Haizhou,Xiao Qiang,Wang Zhiping,Zhang Yuanyuan.Present situation and research progress of dyazide[J].Chemical Technology Market,2008,31(6). |
| |
| Authors: | Liu Haizhou Xiao Qiang Wang Zhiping Zhang Yuanyuan |
| |
| Institution: | Liu Haizhou Xiao Qiang Wang Zhiping Zhang Yuanyuan (Qingdao University of Science , Technology,Qingdao 266042,China) |
| |
| Abstract: | Angiocardiopathy is the number-one killer of treatening people's health,and hypertension is one of the most common disease.In recent years,hypertension has become the major threaten to people's health,which causes the dyazide market develop rapidly.Relevant data showed that the global hypotensive drug market will exceed 58 000 million dollar by 2009,and the annual incremental rate will maintain about 7%. |
| |
| Keywords: | hypertension heart blood vessel angiotonin acceptor |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
